Stem Cell Therapy for Perianal Crohn’s Disease

Aim. To compare the effectiveness of the effect of combination therapy (local and systemic administration) with bone marrow mesenchymal stromal cells (MSC), anticlitokine therapy with infliximab (IFX), and antibiotic (AB)/immunosuppressive (IS) therapy on the frequency of healing of simple perianal...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: O V Knyazev, N A Fadeeva, A V Kagramanova, N I Belyakov, N V Orlova, A A Lishchinskaya, A G Konoplyannikov, A I Parfenov
Médium: Artigo
Jazyk:Russo
Vydáno: "Consilium Medicum" Publishing house 2018-03-01
Edice:Терапевтический архив
Témata:
crohn's disease
infliximab
fistula form
mesenchymal stromal cells
stem cell therapy
On-line přístup:https://ter-arkhiv.ru/0040-3660/article/viewFile/32743/pdf
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky